BRIEF-Benitec Biopharma gets orphan drug designation in EU for BB-301
* Receives orphan drug designation in European Union for BB-301 Source text for Eikon: Further company coverage:
Dec 16 Recro Pharma Inc
* Recro Pharma announces closing of $40 million public offering of common stock Source text for Eikon: Further company coverage:
* Says it gets insurance regulator's approval to set up life insurance firm with partners
LONDON, Jan 17 People recovering from depression but struggling with its effect on memory, concentration and cognitive function may benefit from the stimulant modafinil, according to results of a small study published on Tuesday.